About Solventum Corp.
Ticker
info
SOLV
Trading on
info
NYSE
ISIN
info
US83444M1018
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Bryan C. Hanson
Headquarters
info
1750 Yankee Doodle Road, Eagan, MN, United States, 55121
Employees
info
20,584
Website
info
solventum.com
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Metrics
BasicAdvanced
Market cap
info
$12B
P/E ratio
info
7.78
EPS
info
$8.88
Dividend Yield
info
0.00%
Beta
info
0.77
Forward P/E ratio
info
10.87
EBIDTA
info
$1.17B
Ex dividend date
info
-
Price & volume
Market cap
info
$12B
Average daily volume
info
1.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
7.78
Forward P/E
info
10.87
PEG ratio
info
1.22
Trailing P/E
info
7.78
Price to sales
info
1.44
Price to book
info
2.37
Earnings
EPS
info
$8.88
EPS estimate (current quarter)
info
$1.50
EPS estimate (next quarter)
info
$1.46
EBITDA
info
$1.17B
Revenues (TTM)
info
$8.33B
Revenues per share (TTM)
info
$47.82
Technicals
Beta
info
0.77
52-week High
info
$88.20
52-week Low
info
$62.38
50-day moving average
info
$70.01
200-day moving average
info
$74.28
Short ratio
info
3.67
Short %
info
3.65%
Management effectiveness
ROE (TTM)
info
38.86%
ROA (TTM)
info
2.94%
Profit margin
info
18.69%
Gross profit margin
info
$4.46B
Operating margin
info
7.01%
Growth
Quarterly earnings growth (YoY)
info
100.80%
Quarterly revenue growth (YoY)
info
-3.70%
Share stats
Outstanding Shares
info
173M
Float
info
147M
Insiders %
info
14.99%
Institutions %
info
73.74%
Analyst Insights & forecasts
info

26% Buy

66% Hold

8% Sell

Based on information from 12 analysts.

Average price target

info
$85.17
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.34
$1.57
-14.65%
Q1 • 25Missed
$1.69
$1.68
0.60%
Q2 • 25Beat
$1.50
$1.77
-15.25%
Q3 • 25Missed
$1.57
$1.75
-10.29%
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2.1B
$1.27B
60.40%
Q3 • 25
$2B
$63M
3.15%
Q4 • 25
-4.68%
-95.02%
-94.78%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$14B
$8.99B
64.32%
Q3 • 25
$14.3B
$9.25B
64.68%
Q4 • 25
2.30%
2.87%
0.56%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$76M
$3.77B
$-2.69B
$-21M
Q3 • 25
$95M
-
$-115M
$32M
Q4 • 25
25.00%
-
-95.73%
-252.38%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Solventum Corp. share?
Collapse

Solventum Corp. shares are currently traded for undefined per share.

How many shares does Solventum Corp. have?
Collapse

Solventum Corp. currently has 173M shares.

Does Solventum Corp. pay dividends?
Collapse

No, Solventum Corp. doesn't pay dividends.

What is Solventum Corp. 52 week high?
Collapse

Solventum Corp. 52 week high is $88.20.

What is Solventum Corp. 52 week low?
Collapse

Solventum Corp. 52 week low is $62.38.

What is the 200-day moving average of Solventum Corp.?
Collapse

Solventum Corp. 200-day moving average is $74.28.

Who is Solventum Corp. CEO?
Collapse

The CEO of Solventum Corp. is Bryan C. Hanson.

How many employees Solventum Corp. has?
Collapse

Solventum Corp. has 20,584 employees.

What is the market cap of Solventum Corp.?
Collapse

The market cap of Solventum Corp. is $12B.

What is the P/E of Solventum Corp.?
Collapse

The current P/E of Solventum Corp. is 7.78.

What is the EPS of Solventum Corp.?
Collapse

The EPS of Solventum Corp. is $8.88.

What is the PEG Ratio of Solventum Corp.?
Collapse

The PEG Ratio of Solventum Corp. is 1.22.

What do analysts say about Solventum Corp.?
Collapse

According to the analysts Solventum Corp. is considered a hold.